Data News > Dentsply Sirona Inc. Faces Class Action Lawsuits and Upcoming Deadlines
- Various law firms are notifying Dentsply Sirona Inc. investors of a class action lawsuit and upcoming deadline related to securities fraud.
- The lawsuits cover the period between May 6, 2021, and November 6, 2024, for investors who suffered losses.
- Investors are encouraged to contact legal counsel before the important deadline of January 27, 2025.
- The lawsuits aim to recover damages for alleged violations of federal securities laws.
- Investors with substantial losses have the opportunity to lead the class action lawsuit against Dentsply Sirona Inc.
Several law firms are alerting investors of Dentsply Sirona Inc. about a class action lawsuit and the impending deadline linked to potential securities law violations. Investors who experienced losses on their Dentsply Sirona Inc. (NASDAQ:XRAY) investment are being informed about the opportunity for potential recovery under federal securities laws. The lawsuits cover the period ranging from May 6, 2021, to November 6, 2024, urging investors who purchased or acquired Dentsply Sirona common stock during this timeframe to explore their compensation options without the need for any out-of-pocket expenses through a contingency fee arrangement.
Rosen Law Firm, a global investor rights law firm, emphasizes the significant lead plaintiff deadline of January 27, 2025, for purchasers of common stock of Dentsply Sirona Inc. (NASDAQ:XRAY) during the Class Period. Investors with losses are advised to secure legal counsel before the important deadline to potentially discuss their rights and entitlement to compensation without upfront costs. The firm aims to guide investors in understanding the implications of the lawsuit and any potential recovery available to them.
Lowey Dannenberg P.C., a leading law firm dedicated to obtaining redress for consumers and investors, has filed a class-action lawsuit against Dentsply Sirona Inc. (“Dentsply Sirona,” “Dentsply,” or the “Company”) (NASDAQ: XRAY) for alleged violations of federal securities laws. This lawsuit encompasses investors who purchased or acquired Dentsply Sirona common stock between December 1, 2022, and November 6, 2024, during the specified Class Period. Investors with losses exceeding $100,000 are particularly encouraged to engage with the firm to explore their legal options and potential avenues for recovery before the deadline on January 27, 2025.
Pomerantz Law Firm has also announced the filing of a class action lawsuit against Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ:XRAY) for shareholders who have experienced losses. The firm encourages impacted investors to reach out for further information and counsel regarding the class action lawsuit. Additionally, The Schall Law Firm is inviting shareholders who suffered losses to participate in a securities fraud case against DENTSPLY SIRONA Inc., demonstrating a national effort to seek accountability and redress for affected investors.
Investors are reminded by various legal entities, including Levi & Korsinsky and Bronstein, Gewirtz & Grossman, LLC, about the ongoing class action lawsuits against Dentsply Sirona Inc. related to alleged securities fraud during the Class Period. These legal firms are advocating for investors to take proactive steps and explore their legal rights before the crucial deadline on January 27, 2025. The class action lawsuits aim to address the violations of federal securities laws and recover damages on behalf of impacted investors who purchased or acquired Dentsply securities within the specified timeframe.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Dentsply Sirona Inc. Faces Class Action Lawsuits and Upcoming Deadlines
By KlickAnalytics Data Insights | January 10, 2025 08:02PM ET
Key Points
- Various law firms are notifying Dentsply Sirona Inc. investors of a class action lawsuit and upcoming deadline related to securities fraud.
- The lawsuits cover the period between May 6, 2021, and November 6, 2024, for investors who suffered losses.
- Investors are encouraged to contact legal counsel before the important deadline of January 27, 2025.
- The lawsuits aim to recover damages for alleged violations of federal securities laws.
- Investors with substantial losses have the opportunity to lead the class action lawsuit against Dentsply Sirona Inc.
Several law firms are alerting investors of Dentsply Sirona Inc. about a class action lawsuit and the impending deadline linked to potential securities law violations. Investors who experienced losses on their Dentsply Sirona Inc. (NASDAQ:XRAY) investment are being informed about the opportunity for potential recovery under federal securities laws. The lawsuits cover the period ranging from May 6, 2021, to November 6, 2024, urging investors who purchased or acquired Dentsply Sirona common stock during this timeframe to explore their compensation options without the need for any out-of-pocket expenses through a contingency fee arrangement.
Rosen Law Firm, a global investor rights law firm, emphasizes the significant lead plaintiff deadline of January 27, 2025, for purchasers of common stock of Dentsply Sirona Inc. (NASDAQ:XRAY) during the Class Period. Investors with losses are advised to secure legal counsel before the important deadline to potentially discuss their rights and entitlement to compensation without upfront costs. The firm aims to guide investors in understanding the implications of the lawsuit and any potential recovery available to them.
Lowey Dannenberg P.C., a leading law firm dedicated to obtaining redress for consumers and investors, has filed a class-action lawsuit against Dentsply Sirona Inc. (“Dentsply Sirona,” “Dentsply,” or the “Company”) (NASDAQ: XRAY) for alleged violations of federal securities laws. This lawsuit encompasses investors who purchased or acquired Dentsply Sirona common stock between December 1, 2022, and November 6, 2024, during the specified Class Period. Investors with losses exceeding $100,000 are particularly encouraged to engage with the firm to explore their legal options and potential avenues for recovery before the deadline on January 27, 2025.
Pomerantz Law Firm has also announced the filing of a class action lawsuit against Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ:XRAY) for shareholders who have experienced losses. The firm encourages impacted investors to reach out for further information and counsel regarding the class action lawsuit. Additionally, The Schall Law Firm is inviting shareholders who suffered losses to participate in a securities fraud case against DENTSPLY SIRONA Inc., demonstrating a national effort to seek accountability and redress for affected investors.
Investors are reminded by various legal entities, including Levi & Korsinsky and Bronstein, Gewirtz & Grossman, LLC, about the ongoing class action lawsuits against Dentsply Sirona Inc. related to alleged securities fraud during the Class Period. These legal firms are advocating for investors to take proactive steps and explore their legal rights before the crucial deadline on January 27, 2025. The class action lawsuits aim to address the violations of federal securities laws and recover damages on behalf of impacted investors who purchased or acquired Dentsply securities within the specified timeframe.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.